Related Experiment Video
Updated: Aug 8, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress
Marie Stampe Ostenfeld1, Nicole Fehrenbacher, Maria Høyer-Hansen
1Apoptosis Department, Institute for Cancer Biology, Danish Cancer Society, Copenhagen, Denmark.
Abstract:
Acquired resistance to classic caspase-mediated apoptosis is a common problem for the treatment of human cancer. Here, we show that siramesine, a novel sigma-2 receptor ligand, effectively induces caspase-independent programmed cell death in immortalized and transformed cells of various origins. Siramesine-treated tumor cells displayed increased levels of reactive oxygen species, lysosomal membrane permeabilization, chromatin condensation, and shrinkage and detachment of cells. Lipid antioxidants (alpha-tocopherol and gamma-tocopherol), but not other tested antioxidants (butylated hydroxyanisol or N-acetyl cysteine), effectively inhibited siramesine-induced morphologic changes and cell death. Cathepsin B inhibitors (CA-074-Me and R-2525) conferred similar, but less pronounced protection, whereas ectopic expression of antiapoptotic protein Bcl-2, lack of wild-type p53 as well as pharmacologic inhibitors of caspases (zVAD-fmk, DEVD-CHO, and LEHD-CHO), calpains (PD150606), and serine proteases (N-tosyl-L-phenylalanine chloromethyl ketone and pefabloc) failed to protect cells against siramesine-induced death. Importantly, transformation of murine embryonic fibroblasts with activated c-src or v-Ha-ras oncogenes greatly sensitized them to siramesine-induced cytotoxicity. Furthermore, p.o. administration of well-tolerated doses of siramesine had a significant antitumorigenic effect in orthotopic breast cancer and s.c. fibrosarcoma models in mice. These results present siramesine as a promising new drug for the treatment of tumors resistant to traditional therapies.
Insights
Siramesine, a sigma-2 receptor ligand, induces programmed cell death independent of caspases in cancer cells. This novel compound shows promise as an anti-cancer drug for tumors resistant to traditional therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Acquired resistance to caspase-mediated apoptosis is a significant challenge in human cancer treatment.
- Novel therapeutic strategies are needed to overcome resistance to conventional cancer therapies.
Purpose of the Study:
- To investigate the potential of siramesine, a sigma-2 receptor ligand, in inducing cancer cell death.
- To elucidate the mechanism of siramesine-induced cell death and its efficacy in preclinical cancer models.
Main Methods:
- Siramesine was used to treat immortalized and transformed cells, and its effects on cell death pathways were analyzed.
- Reactive oxygen species (ROS) levels, lysosomal membrane permeabilization, and morphologic changes were assessed.
- The role of antioxidants, cathepsin B, Bcl-2, p53, and various protease inhibitors in siramesine-induced cell death was evaluated.
- The impact of oncogene transformation on siramesine sensitivity was studied.
- Antitumorigenic effects of siramesine were tested in murine breast cancer and fibrosarcoma models.
Main Results:
- Siramesine induced caspase-independent programmed cell death, characterized by increased ROS, lysosomal permeabilization, and cellular changes.
- Lipid-soluble antioxidants (alpha- and gamma-tocopherol) protected cells, while cathepsin B inhibitors offered partial protection.
- Bcl-2 overexpression, p53 deficiency, and inhibitors of caspases, calpains, or serine proteases did not prevent siramesine-induced death.
- Oncogenic transformation with c-src or v-Ha-ras sensitized cells to siramesine.
- Siramesine demonstrated significant antitumorigenic effects in vivo in mouse models.
Conclusions:
- Siramesine effectively triggers a unique form of programmed cell death that bypasses caspase pathways.
- The drug's mechanism involves oxidative stress and lysosomal destabilization, with lipid antioxidants showing protective effects.
- Siramesine exhibits potent antitumor activity in preclinical models, highlighting its potential as a therapeutic agent for drug-resistant cancers.
More Related Videos
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury IlI: Cellular Death

